American Pharmacy News
  • People
  • Innovation
  • Regulatory
  • Industry
  • Federal Issues
  • State Issues
  • Directory
  • People
  • Innovation
  • Regulatory
  • Industry
  • Federal Issues
  • State Issues
  • Directory
  • Home
  • »
  • Stories
  • »
  • District of Columbia

Plaintiff lawyer ads may scare some Americans from taking their prescriptions, finds new survey

LocalLabs News Service | Jun 22, 2017

Do television ads by plaintiffs' lawyer firms hawking lawsuits over prescription drugs cause patients to cease taking their prescribed prescriptions? Read More »

Study shows gifts, relationships with drug company representatives, influence physicians

John Breslin | Jun 19, 2017
Researchers don't believe doctors are being bought in the traditional sense, but that they may be swayed by simple human interaction.

A new study published in the Journal of the American Medical Association finds that doctors are influenced by gifts and their relationships with drug company representatives. Read More »

Study shows promise for antiandrogens in prostate cancer treatment

American Pharmacy News Reports | Jun 16, 2017
The study compared the antiandrogen therapy with radiation therapy plus placebo.

The American Pharmacists Association (APA) recently announced that new research shows adding 24 months of antiandrogen therapy with daily bicalutamide to salvage radiation therapy led to an increase in survival rates and for patients with recurrent prostate cancer. Read More »

Legal expert issues warning over federal disclosure bills aimed at pharmacy benefit managers

John Breslin | Jun 12, 2017
Joanna Shepherd, professor, Emory School of Law

Government-mandated disclosure bills could have a negative impact on competition if pharmacy benefit managers are forced to publicly disclose too much information on their negotiations with drug companies, according to Emory School of Law professor Joanna Shepherd. Read More »

SCOTUS ruling in Sandoz v. Amgen will speed biosimilars to market, could save U.S. consumers billions

LocalLabs News Service | Jun 12, 2017

The U.S. Supreme Court issued a 9-0 ruling today that will have the effect of speeding the process for biosimilars going to market. Read More »

Drug companies set prices unrelated to rebates, according to PBM industry group study

Carol Ostrow | Jun 12, 2017
PCMA published its research in its “Increasing Prices Set by Drugmakers Not Correlated With Rebates” report.

As a Senate committee prepares to evaluate U.S. drug distribution at a hearing tomorrow, the Pharmaceutical Care Management Association readily demonstrates that manufacturers’ pricing does not correlate with agreed-upon rebates and discounts with pharmacy benefit managers. Read More »

Government waste watchdog group urges Nevada governor to veto Rx 'transparency' bill

LocalLabs News Service | Jun 8, 2017

A Nevada bill headed to the desk of Governor Brian Sandoval (R) would do nothing to decrease prescription drug costs, according to the Council of Citizens Against Government Waste (CCAGW). Read More »

Technavio projects explosive growth for pharmaceutical packaging market

Tabitha Fleming | Jun 4, 2017
The market for parenteral containers -- containers that include vials, injections, ampoules and pre-filled syringes -- is expected to grow.

According to the Technavio’s latest market study, the North American pharmaceutical packaging market is expected to grow through 2021. Read More »

PCMA applauds FDA attempts to stop prescription drug price-fixing

American Pharmacy News Reports | Jun 4, 2017
Generic medications provide a lower cost alternative to consumers.

The Pharmaceutical Care Management Association (PCMA) released a statement in support of the Food and Drug Commissioner’s call to publish a list of off-patent drugs that may be vulnerable to price-fixing. Read More »

PBMs changing the face of pharmacies

American Pharmacy News Reports | May 23, 2017
Specialty pharmacies harness the expertise of pharmacists, nurses, social workers and insurance professionals.

Pharmacy benefit managers are changing the way that prescriptions are filled, reducing the costs for patients and increasing the value for all involved. Read More »

Results on anti-malarial drug Tafenoquine accepted for publication

American Pharmacy News Reports | May 20, 2017
The study determined the maximum tolerated dosages of tafenoquine, which is an investigational antimalarial agent.

60 Degrees Pharmaceuticals' study findings on tafenoquine have been published in Travel Medicine and Infectious Disease. Read More »

Fred's purchase of 865 Rite Aid stores moves forward

American Pharmacy News Reports | May 18, 2017
Fred’s Pharmacy continues to work with the FTC, Rite Aid and Walgreens to complete the transaction.

Fred’s Inc.'s plans to buy 865 Rite Aid stores for $950 million is still active. Read More »

Generic prescription prices hold steady as brand name drugs jump 12.9 percent

John Breslin | May 18, 2017
The Fair Accountability and Innovative Research (FAIR) Drug Pricing Act was introduced by Sens. John McCain (R-AZ) and Tammy Baldwin (D-WI), along with Rep. Jan Schakowsky (D-IL)

The cost of generic prescription drugs rose at a much slower rate than brand name drugs in 2016, according to an annual national drug index released by Truveris. Read More »

ALS Association applauds Radicava approval

American Pharmacy News Reports | May 13, 2017
Radicava (edaravone) is the first ALS drug to be approved specifically for treatment of the disease since 1995.

The first new drug approved specifically to treat amyotrophic lateral sclerosis (ALS), commonly referred to a Lou Gehrig’s Disease, in over two decades was approved in less than a year, thanks in large part to the FDA working in conjunction with Mitsubishi Tanabe Pharma Corp. and the ALS Association. Read More »

Pharmacy Benefits Managers can be more affordable option than drugstores

American Pharmacy News Reports | May 1, 2017
The new agenda of drugstores would seek to increase their profit, while costing consumers more.

The Pharmaceutical Care Management Association is beginning the DrugBenefitSolutions national campaign, in which it seeks to explain how pharmacy benefits managers are helping to reduce the price of medications and assist consumers, as well as employers and unions. Read More »

PCMA urges FDA to consider competitive drug pricing

American Pharmacy News Reports | Apr 26, 2017

The Pharmaceutical Care Management Association (PCMA) has recommended that the next Food and Drug Administration (FDA) director adopt five specific strategies to encourage pharmaceutical pricing competition based on results of its recently commissioned report. Read More »

'Meds to beds': personal delivery helps patients following hospital discharge

Carrie Bradon | Apr 21, 2017

Bedside delivery of medications is a practice that is helping patients live more healthily following discharge from hospitals. Read More »

No correlation exists between drug prices and rebates, study says

American Pharmacy News Reports | Apr 20, 2017

An analysis commissioned by Washington, D.C.’s Pharmaceutical Care Management Association (PCMA) recently confirmed that no correlation exists between prices and rebates contrary to claims that drug costs are proportional to consumer rebates and discounts. Read More »

Experts argue pharmacists are first line of defense in opioid epidemic

Tabitha Fleming | Apr 12, 2017
The prevalence of opioid abuse was the topic of a recent special issue of the Journal of the American Pharmacists Association.

Pharmacists and the difficult balance they must keep between patients suffering from chronic pain and the prevalence opioid abuse was the topic of a recent special issue of the Journal of the American Pharmacists Association Read More »

PCMA critical of PhRMA ad, calling it an attempt to deflect blame

American Pharmacy News Reports | Apr 12, 2017
The PCMA calls the new ad campaign a “losing strategy.

Prescription drug costs battles are far from over as PCMA calls for the drug lobby to stop deflecting blame in an effort to maintain profit margins. Read More »

  • «
  • 1
  • 2
  • 3
  • 4 (current)
  • 5
  • 6
  • ...
  • 14
  • 15
  • »
Trending

Brianna Allen, Senior Director of Public Affairs at PhRMA

PhRMA senior director on 340B program: 'Hospitals abuse the program to boost their profits at the expense of patients'

Dan DeNeui, CEO of FarmaKeio

Iowa board files charges against FarmaKeio, citing FDA and California actions

Lenora S. Newsome PD Chairperson

Potential medication mix-ups between Inflectra and Zymfentra prompt safety warnings

Shaun Noorian, CEO of Empower Pharmacy

Trader on Eli Lilly lawsuit: 'There is decades of legal precedent allowing the compounding of medications under the 503A exemption'

Luke Gale, Revenue Cycle Editor, HealthLeaders Media

HealthLeaders editor on 340B: ‘We continue to have serious concerns about persistent and often illegal abuse of 340B’

Copyright © 2025 American Pharmacy News. All Rights Reserved.

  • About
  • Contact
  • Privacy Policy
  • Terms of Service

Alerts Sign-up